BRCA1 and breast carcinoma: Approximately 70% of breast tumors containing germline BRCA1 mutations are diagnosed as triple-negative breast cancer (TNBC), a highly aggressive subtype of breast cancer associated with poor outcomes due to limited treatment options [2, 4].